INSPIRED BY successful campaigns to support research and treatment for breast cancer, the American Cancer Society (ACS) is mounting a new initiative in an attempt to make an impact on prostate cancer.
At a press conference in Washington, DC, last month, it issued a National Blueprint for Action, a set of proposals for dealing with the disease, to which it will devote $8 million to $10 million annually.
Because prostate cancer disproportionately affects African American men, the call for action is primarily addressed to them. But any benefits from the initiative are expected to affect the clinical management of the disease overall.
Between 1976 and 1994, prostate cancer rates doubled from around 73 cases per 100000 men to 144 cases per 100000, and mortality rose from 22 cases per 100000 in 1976 to 26.7 cases per 100000 men in 1992 (CA Cancer J Clin. 1997;47:273-287). Although the . . . [Full Text of this Article]